(MENAFN- IANS) New Delhi, Feb 28 (IANS) Leading homegrown robotics company Addverb on Wednesday unveiled India's first-ever assistive dog robot named 'Trakr' at LogiMAT India 2024.
Along with 'Trakr', the company unveiled an advanced medical collaborative robot (cobot) for rehabilitation and imaging, named 'Heal' and a cobot designed to enhance operational efficiency and safety, named 'Syncro'.
"Trakr's agility, Heal's medical advancements, and Syncro's collaborative prowess promise to redefine operational standards. We're proud to offer solutions that not only enhance efficiency but also cater to diverse industry needs, marking a milestone in flexible automation," Sangeet Kumar, Co-founder & CEO, Addverb, said in a statement.
According to the company, 'Trakr' represents a technological milestone, engineered for agility and perception.
Its versatility extends across industries such as construction, oil exploration, Defence, and security.
Operating autonomously, 'Trakr' excels in facility inspections, patrols, and surveillance, making it a pioneering addition to any workforce, it added.
'Heal' transforms healthcare with an innovative approach to rehabilitation and imaging.
Specialising in collaborative human-robot interactions, it focuses on physical and rehabilitation therapy for stroke patients and aids in remote imaging procedures like ultrasound and MRI scans.
'Syncro' is engineered to work alongside humans in shared spaces, the company said.
Boasting advanced safety features, adaptability, and ease of use, it finds application across diverse tasks from manufacturing to logistics.
Launched in 2016, Addverb provides smart end-to-end robots for warehouses and industrial automation.
MENAFN28022024000231011071ID1107911160
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.